UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit-Risk Balance of Medicines

Clinical pharmacology and therapeutics, 2011-02, Vol.89 (2), p.312-315

2011

Volltextzugriff (PDF)

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting

Clinical pharmacology and therapeutics, 2016-09, Vol.100 (3), p.275-286

2016

Volltextzugriff (PDF)

Application of the BRAT Framework to Case Studies: Observations and Insights

Clinical pharmacology and therapeutics, 2011-02, Vol.89 (2), p.217-224

2011

Volltextzugriff (PDF)

Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring

AIDS research and human retroviruses, 2009-05, Vol.25 (5), p.483

2009

Volltextzugriff (PDF)

(453) The risk of cardiovascular events in opioid agonist/antagonist combination products compared to other ER opioids

The journal of pain, 2014-04, Vol.15 (4), p.S89-S89

2014

Volltextzugriff (PDF)

(135) Comparison of the risk of opioid overdose among patients prescribed immediate-release and extended-release opioid analgesics

The journal of pain, 2014-04, Vol.15 (4), p.S9-S9

2014

Volltextzugriff (PDF)

Hepatitis B Vaccination and the Risk of Multiple Sclerosis

The New England journal of medicine, 2001-02, Vol.344 (5), p.327-332

2001

Volltextzugriff (PDF)

Comparison of Clinical Outcomes of Gripping Surface Technology Staple Reloads versus Standard Staple Reloads Used with Manual Linear Surgical Staplers

Medical devices (Auckland, N.Z.), 2022-01, Vol.15, p.385-399

2022

Volltextzugriff (PDF)

Long-term efficacy and safety of opioid therapy for chronic non-cancer pain: evidence from randomized and open-label studies

The journal of pain, 2013-04, Vol.14 (4), p.S77-S77

2013

Volltextzugriff (PDF)

Comparison of overdose rates among patients prescribed buprenorphine patch, fentanyl, patch and morphine in the UK

The journal of pain, 2013-04, Vol.14 (4), p.S82-S82

2013

Volltextzugriff (PDF)

What's the difference? Within-patient versus between-patient designs to evaluate the effects of long-term opioid therapy

The journal of pain, 2013-04, Vol.14 (4), p.S78-S78

2013

Volltextzugriff (PDF)

Duration of use of extended-release oxycodone and morphine among adults with cancer and non-cancer pain

The journal of pain, 2013-04, Vol.14 (4), p.S75-S75

2013

Volltextzugriff (PDF)

The risk of opioid overdose among patients receiving higher versus lower doses of extended-release opioids in the UK

The journal of pain, 2013-04, Vol.14 (4), p.S18-S18

2013

Volltextzugriff (PDF)

Effects of reformulated OxyContin® on opioid abuse in the National Poison Data System

The journal of pain, 2012-04, Vol.13 (4), p.S83-S83

2012

Volltextzugriff (PDF)

PND36 Structured Benefit-Risk Assessment of Triptan Treatments Using Patient-Preference Data

Value in health, 2012-06, Vol.15 (4), p.A147-A147

2012

Volltextzugriff (PDF)

PSY48 Butrans® Rems Health Care Provider Training Guide Recall Testing

Value in health, 2012-06, Vol.15 (4), p.A107-A107

2012

Volltextzugriff (PDF)

92 Difference in Rates of Abuse Following Reformulation of Extended Release Oxycodone Using Data From the RADARS® System Poison Center Program

Annals of emergency medicine, 2012-10, Vol.60 (4), p.S34-S35

2012

Volltextzugriff (PDF)

Effects of reformulated OxyContin® among patients assessed for substance abuse treatment in the NAVIPPRO sentinel surveillance network

The journal of pain, 2012-04, Vol.13 (4), p.S58-S58

2012

Volltextzugriff (PDF)

A comparison of the street price of original and reformulated OxyContin® and immediate release (IR) oxycodone products

The journal of pain, 2012-04, Vol.13 (4), p.S26-S26

2012

Volltextzugriff (PDF)

100.63 In-Hospital Safety and Effectiveness of Non-Emergent, MCS-Supported High-Risk PCI Procedures: A Comprehensive Propensity-Score Matched Analysis of Contemporary, Large-Scale Claims Dataset

JACC. Cardiovascular interventions, 2024-02, Vol.17 (4), p.S18-S18

2024

Volltextzugriff (PDF)

93 Changes in Diversion Rates Following the Introduction of a Reformulated Extended Release Oxycodone Product

Annals of emergency medicine, 2012-10, Vol.60 (4), p.S35-S35

2012

Volltextzugriff (PDF)

Postlicensure study of varicella vaccine effectiveness in a day-care setting

The Pediatric infectious disease journal, 1999-12, Vol.18 (12), p.1047-1050

1999

Volltextzugriff (PDF)

Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION review and checklist

The journal of pain, 2013-04, Vol.14 (4), p.S10-S10

2013

Volltextzugriff (PDF)

PMD49 COMPARISON OF CARDINALITY MATCHING VS PROPENSITY SCORE MATCHING FOR TARGETED ESTIMANDS

Value in health, 2020-05, Vol.23, p.S198-S198

2020

Volltextzugriff (PDF)

Discrepancies between published and registered primary outcomes in analgesic trials: ACTTION systematic review

The journal of pain, 2013-04, Vol.14 (4), p.S10-S10

2013

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(243)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(144)
Life Sciences & Biomedicine
(104)
Humans
(97)
Male
(63)
Biological And Medical Sciences
(61)
Female
(59)
Medical Sciences
(56)
Adult
(35)
Physical Sciences
(32)
Infectious Diseases
(28)
Psychiatry
(27)
Neurosciences & Neurology
(25)
Middle Aged
(24)
Neurosciences
(22)
Physics
(21)
Animals
(20)
Adolescent
(17)
Fundamental And Applied Biological Sciences. Psychology
(17)
Immunology
(17)
Child
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit-Risk Balance of Medicines

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting

Application of the BRAT Framework to Case Studies: Observations and Insights

Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring

(453) The risk of cardiovascular events in opioid agonist/antagonist combination products compared to other ER opioids

(135) Comparison of the risk of opioid overdose among patients prescribed immediate-release and extended-release opioid analgesics

Hepatitis B Vaccination and the Risk of Multiple Sclerosis

Comparison of Clinical Outcomes of Gripping Surface Technology Staple Reloads versus Standard Staple Reloads Used with Manual Linear Surgical Staplers

Long-term efficacy and safety of opioid therapy for chronic non-cancer pain: evidence from randomized and open-label studies

Comparison of overdose rates among patients prescribed buprenorphine patch, fentanyl, patch and morphine in the UK

What's the difference? Within-patient versus between-patient designs to evaluate the effects of long-term opioid therapy

Duration of use of extended-release oxycodone and morphine among adults with cancer and non-cancer pain

The risk of opioid overdose among patients receiving higher versus lower doses of extended-release opioids in the UK

Effects of reformulated OxyContin® on opioid abuse in the National Poison Data System

PND36 Structured Benefit-Risk Assessment of Triptan Treatments Using Patient-Preference Data

PSY48 Butrans® Rems Health Care Provider Training Guide Recall Testing

92 Difference in Rates of Abuse Following Reformulation of Extended Release Oxycodone Using Data From the RADARS® System Poison Center Program

Effects of reformulated OxyContin® among patients assessed for substance abuse treatment in the NAVIPPRO sentinel surveillance network

A comparison of the street price of original and reformulated OxyContin® and immediate release (IR) oxycodone products

100.63 In-Hospital Safety and Effectiveness of Non-Emergent, MCS-Supported High-Risk PCI Procedures: A Comprehensive Propensity-Score Matched Analysis of Contemporary, Large-Scale Claims Dataset

93 Changes in Diversion Rates Following the Introduction of a Reformulated Extended Release Oxycodone Product

Postlicensure study of varicella vaccine effectiveness in a day-care setting

Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION review and checklist

PMD49 COMPARISON OF CARDINALITY MATCHING VS PROPENSITY SCORE MATCHING FOR TARGETED ESTIMANDS

Discrepancies between published and registered primary outcomes in analgesic trials: ACTTION systematic review

Suchergebnisse filtern